Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search
Fullscreen

For citation:


Avxentyev N.A., Makarov A.S., Frolov M.Y. Direct medical costs of using enzalutamide or abiraterone in chemotherapy-naïve patients with metastatic castration resistant prostate cancer. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2018;11(4):16-27. (In Russ.) https://doi.org/10.17749/2070-4909.2018.11.4.016-027

Views: 42


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)